Similarly, there was a significant elevation in ATG13 concentrations in the kidneys of the CIS-treated Gal-3 KO mice compared to Gal-3 KO sham control mice, also demonstrating statistical significance (p < 0.001) (Figure 10A). The gene discussed is ATG13; the disease is in situ carcinoma.